Drug eluting balloon is a semi-compliant angioplasty balloon, coated with anti-proliferative medicine. The medicine is ejected to the vessel walls during the inflation of the balloon. The balloons are inflated through application of nominal pressure. The active substance of the balloon is highly lipophilic in nature. Drug eluting balloon homogeneously delivers the drug to the vessel and prevents neointimal hyperplasia (proliferation of vascular smooth muscle and thickening of arterial wall, thus reducing the arterial lumen space). The device has gained popularity as it helps in effective treatment of in-stent restenosis as compared to drug eluting stent or bare metal stent. Rise in peripheral and coronary artery diseases among the geriatric population is likely to drive the global drug eluting balloon market in the near future.
In 2019, the market size of Drug-Eluting Balloons is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Drug-Eluting Balloons.
This report studies the global market size of Drug-Eluting Balloons, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Drug-Eluting Balloons production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Boston Scientific
Medtronic
Cook Medical
C.R. Bard
B. Braun
Eurocor GmbH
Blue Medical
Bayer
Aachen Resonance
Acrostak
Market Segment by Product Type
Coronary Drug Eluting Balloon
Peripheral Drug Eluting Balloon
Others
Market Segment by Application
Hospitals and Ambulatory Surgery Centers
CATH Labs
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Drug-Eluting Balloons status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Drug-Eluting Balloons manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Drug-Eluting Balloons are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Summary:
Get latest Market Research Reports on Drug-Eluting Balloons . Industry analysis & Market Report on Drug-Eluting Balloons is a syndicated market report, published as Global (United States, European Union and China) Drug-Eluting Balloons Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Drug-Eluting Balloons market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.